Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
32 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Science


RSS FeedsVBI Vaccines and Brii Biosciences Initiate Phase 1b/2a Study of BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B Infection
(WorldNews Health)

 
 

14 november 2019 15:47:14

 
VBI Vaccines and Brii Biosciences Initiate Phase 1b/2a Study of BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B Infection
(WorldNews Health)
 


VBI Vaccines Inc. (NASDAQ: VBIV) (`VBI`), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, and Brii Biosciences (`Brii Bio`), a clinical-stage company committed to serving patients` needs and improving public health in China and around the world, today announced the first patient dosed in a Phase 1b/2a proof-of-concept study of BRII-179 (VBI-2601), a novel recombinant, protein-based immuno-therapeutic candidate in...


 
7 viewsCategory: Science > Medicine
 
Global Sciatica Market Insights, Epidemiology and Market Forecasts, 2017-2028 - ResearchAndMarkets.com
(WorldNews Health)
Rubius Therapeutics Reports Third Quarter 2019 Financial Results and Operational Progress
(WorldNews Health)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten